Table 3.
C-index analysis of the prognostic accuracy of OV6, CD68 and other variables for overall survival and progression-free survival in the training cohorts (n = 153) (1:1 ratio).
| C-index (95% CI) | Overall survival | Progression-free survival |
|---|---|---|
| Training Cohort (n = 153) | ||
| Tumor Size | 0.638 (0.550–0.726) | 0.597 (0.504–0.689) |
| MVI | 0.609 (0.519–0.699) | 0.634 (0.543–0.725) |
| OV6 | 0.728 (0.646–0.811) | 0.673 (0.586–0.760) |
| CD68 | 0.696 (0.610–0.782) | 0.652 (0.566–0.739) |
| OV6+CD68 | 0.782 (0.707–0.857) | 0.714 (0.633–0.795) |
| OV6+Tumor Size+MVI | 0.799 (0.729–0.869) | 0.754 (0.676–0.832) |
| CD68+Tumor Size+MVI | 0.772 (0.698–0.847) | 0.745 (0.666–0.824) |
| OV6+CD68+Tumor Size+MVI | 0.829 (0.764–0.894) | 0.772 (0.698–0.846) |
MVI, microvascular invasion; CI, confidence interval.